NEOGENOMICS, INC. (NEO) Capital expenditures 2016–2025
NEOGENOMICS, INC. (NEO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$27.0MFY2025 · since FY2016: $7.5M → $27.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $27.0M | -34.2% |
| FY2024 | $41.1M | +42.8% |
| FY2023 | $28.8M | -6.9% |
| FY2022 | $30.9M | -51.8% |
| FY2021 | $64.1M | +120.4% |
| FY2020 | $29.1M | +45.3% |
| FY2019 | $20.0M | +40.0% |
| FY2018 | $14.3M | +4.5% |
| FY2017 | $13.7M | +81.7% |
| FY2016 | $7.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice